Porth Ymchwil

HLA-B*5701 and abacavir hypersensitivity - Reply.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

HLA-B*5701 and abacavir hypersensitivity - Reply. / Hughes, D.; Hughes, D.A.; Park, B.K. et al.
Yn: Pharmacogenetics, Cyfrol 14, Rhif 11, 01.11.2004, t. 784.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Hughes, DA, Park, BK & Pirmohamed, M 2004, 'HLA-B*5701 and abacavir hypersensitivity - Reply.', Pharmacogenetics, cyfrol. 14, rhif 11, tt. 784.

APA

Hughes, D., Hughes, D. A., Park, B. K., & Pirmohamed, M. (2004). HLA-B*5701 and abacavir hypersensitivity - Reply. Pharmacogenetics, 14(11), 784.

CBE

Hughes D, Hughes DA, Park BK, Pirmohamed M. 2004. HLA-B*5701 and abacavir hypersensitivity - Reply. Pharmacogenetics. 14(11):784.

MLA

Hughes, D. et al. "HLA-B*5701 and abacavir hypersensitivity - Reply.". Pharmacogenetics. 2004, 14(11). 784.

VancouverVancouver

Hughes D, Hughes DA, Park BK, Pirmohamed M. HLA-B*5701 and abacavir hypersensitivity - Reply. Pharmacogenetics. 2004 Tach 1;14(11):784.

Author

Hughes, D. ; Hughes, D.A. ; Park, B.K. et al. / HLA-B*5701 and abacavir hypersensitivity - Reply. Yn: Pharmacogenetics. 2004 ; Cyfrol 14, Rhif 11. tt. 784.

RIS

TY - JOUR

T1 - HLA-B*5701 and abacavir hypersensitivity - Reply.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Park, B.K.

AU - Pirmohamed, M.

PY - 2004/11/1

Y1 - 2004/11/1

KW - BIOTECHNOLOGY & APPLIED MICROBIOLOGY

KW - GENETICS & HEREDITY

KW - PHARMACOLOGY & PHARMACY

M3 - Article

VL - 14

SP - 784

JO - Pharmacogenetics

JF - Pharmacogenetics

SN - 0960-314X

IS - 11

ER -